Collagenase Purification for Neutral Protease Removal
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing collagenase manufacturing processes result in atypical degradation due to the presence of neutral protease, which is highly active in the presence of certain metals, leading to purity failures and safety concerns for medical applications.
Innovation Solution
Implementing process controls to manage metal levels during fermentation and purification, specifically maintaining zinc levels below 3 ppm and nickel levels below 0.5 ppm, and incorporating neutral protease elimination steps to ensure collagenase compositions are essentially free of neutral protease, using methods such as SDS-PAGE and Zymography to reject impure fractions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If metal levels are maintained during fermentation and purification, then collagenase stability and reproducibility are improved, but process complexity increases
Solution Approach 1:
The patent applies preliminary action by controlling metal levels (zinc below 3 ppm, nickel below 0.5 ppm) during the fermentation and purification stages before collagenase production. This preventive approach ensures that neutral protease remains inactive throughout the process, avoiding degradation issues later and improving overall process reliability without requiring complex intervention steps downstream.
Solution Approach 2:
The patent implements parameter changes by establishing specific metal concentration thresholds (zinc < 3 ppm, nickel < 0.5 ppm) as critical process parameters. By monitoring and controlling these chemical parameters throughout fermentation and purification, the process achieves consistent collagenase quality and stability while managing complexity through defined parameter specifications rather than complex procedural interventions.
2Manufacturing precision
If neutral protease elimination steps are implemented, then collagenase purity is improved, but manufacturing time and cost increase
Solution Approach 1:
The patent applies the extraction principle by removing neutral protease through specific elimination steps during the purification process. By actively separating and eliminating this contaminating enzyme, the process achieves high collagenase purity (>95%) and prevents degradation, with the trade-off of additional processing steps that increase manufacturing time and complexity.
Solution Approach 2:
The patent employs analytical detection methods (SDS-PAGE and Zymography) to replace extensive manual purification steps. These detection techniques allow for precise identification of neutral protease contamination, enabling targeted elimination and achieving high purity levels more efficiently than traditional mechanical separation methods alone.
3Object-affected harmful factors
If metal levels are strictly controlled below threshold values, then neutral protease activity is suppressed, but process monitoring complexity increases
Solution Approach 1:
The patent implements feedback control by establishing clear metal level thresholds (zinc < 3 ppm, nickel < 0.5 ppm) and monitoring these parameters throughout the process. This feedback mechanism allows operators to adjust conditions in real-time to maintain suppressive metal levels, preventing neutral protease activation while managing monitoring complexity through defined target values and ranges.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution achieves highly pure collagenase products with improved reproducibility and stability, ensuring safety and efficacy for medical treatments by minimizing degradation and maintaining purity above 95% as measured by RP-HPLC.
Implementation Method 1
using methods such as SDS-PAGE and Zymography to reject impure fractions
Implementation Method 2
using methods such as SDS-PAGE and Zymography to reject impure fractions
Implementation Method 3
purity and stability of collagenase I and collagenase II compositions, wherein the compositions are pure to at least 95% by area as measured by reverse phase high pressure liquid chromatography (RP-HPLC)
Data Source
AI summary
The present invention relates to the fields of collagenase production and collagenase products, and particularly to improving the reproducibility, purity, and stability of collagenase I and collagenase II compositions, where the compositions are pure to at least 95% by area as measured by reverse phase high pressure liquid chromatography (RP-HPLC) and essentially free of neutral protease.


